Actively Recruiting
Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia
Led by Ain Shams Maternity Hospital · Updated on 2025-01-24
400
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is: What are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia? Participants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.
CONDITIONS
Official Title
Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospital records of patients diagnosed with preeclampsia with severe features planned to receive magnesium sulphate
You will not qualify if you...
- Records missing data about the magnesium sulphate regimen used
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams University Maternity Hospital
Cairo, Egypt
Actively Recruiting
Research Team
R
Rania HM Ahmed, MD
CONTACT
S
Sherif Ashoush, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here